Bristol-Myers Squibb Company (BMY) Stock Forecast
US · Healthcare
Current price
$55.39
Market cap
$113.11B
Mean price target
$63.08
Implied upside
13.9%
Key takeaways
- Analysts rate Bristol-Myers Squibb Company a “None”, with a mean price target of $63.08 — about 13.9% upside from the current $55.39, based on 25 analysts.
- BMY is trading in the middle of its 52-week range, at 63% of the $42.52–$62.89 band.
Analyst consensus
| Consensus rating | None |
|---|---|
| Number of analysts | 25 |
| Mean target | $63.08 |
| High target | $75.00 |
| Low target | $40.00 |
| Rating split (SB / B / H / S / SS) | 4 / 6 / 18 / 1 / 0 |
Price & trading
| Current price | $55.39 |
|---|---|
| Previous close | $55.00 |
| 52-week high | $62.89 |
| 52-week low | $42.52 |
| 50-day average | $57.15 |
| Beta | 0.24 |
See the full BMY breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Bristol-Myers Squibb Company (BMY) share price?
- Bristol-Myers Squibb Company last traded at $55.39 with a market capitalisation of about $113.1B.
- What is the analyst price target for BMY?
- The mean analyst price target for Bristol-Myers Squibb Company is $63.08, roughly 13.9% above the latest price. The current consensus rating is “None”.
- Where can I see Bristol-Myers Squibb Company's full financial metrics?
- Luminoso tracks BMY's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.